Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial-Reference-Cited by-同舟云学术

Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial

Published:2016-07 Issue:3 Volume:19 Page:346-351
ISSN:1094-6950
Container-title:Journal of Clinical Densitometry
language:en
Short-container-title:Journal of Clinical Densitometry

Author:

Leder Benjamin Z.,Tsai Joy N.,Neer Robert M.,Uihlein Alexander V.,Wallace Paul M.,Burnett-Bowie Sherri-Ann M.

Funder

Eli Lilly Inc. and Amgen Inc.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference25 articles.

1. Adult Official Position of the International Society of Clinical Densitometry 2015 Update. http://www.iscd.org/official-positions/2015-iscd-official-positions-adult/

2. Denosumab for prevention of fractures in postmenopausal women with osteoporosis;Cummings;N Engl J Med,2009

3. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis;Neer;N Engl J Med,2001

4. Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis;Chen;J Bone Miner Res,2006

5. Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures;Austin;J Bone Miner Res,2012

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Horizons: Translational Aspects of Osteomorphs;The Journal of Clinical Endocrinology & Metabolism;2023-12-07

2. Comparative study in estrogen-depleted mice identifies skeletal and osteocyte transcriptomic responses to abaloparatide and teriparatide;JCI Insight;2023-10-23

3. A Delphi consensus on the management of Spanish patients with osteoporosis at high risk of fracture: OSARIDELPHI study;Archives of Osteoporosis;2023-08-23

4. Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials;EUR REV MED PHARMACO;2023

5. Cellular Senescence in Bone;Physiology;2022-09-14